Literature DB >> 16242188

Modulation of sensory photophobia in essential blepharospasm with chromatic lenses.

Natasha L Herz1, Michael T Yen.   

Abstract

PURPOSE: To determine the effect of photochromatic modulation with tinted lenses on the sensory symptoms of photophobia in blepharospasm patients.
DESIGN: Nonrandomized case-control study. PARTICIPANTS: Thirty-four subjects (24 benign essential blepharospasm patients and 10 normal controls).
METHODS: Subjects were seated in front of a calibrated light source. Beginning at 0%, the intensity of the light source was increased gradually until the patient reported symptomatic photophobia. The intensity of the light source was then measured with a light meter. This procedure was performed first with no chromatic lens and then with 7 different chromatic lenses, each blocking specific wavelengths of the visible spectrum. The subject was then asked which lens provided the greatest symptomatic improvement of photophobia. Statistical significance was calculated with analysis of variance and t test analysis. MAIN OUTCOME MEASURES: Objective measurement of light intensity tolerated and subjective assessment of photophobia were obtained for each chromatic lens tested.
RESULTS: The light intensity tolerated by the normal subjects compared with the blepharospasm group was not statistically significant with no lens, but grew to 3.5 times that tolerated by the blepharospasm group as more of the higher wavelengths of the visible spectrum were blocked (P = 0.048). Lenses 4, 5, 6, and 7 allowed blepharospasm patients to tolerate a significantly higher intensity of light when compared with no lens (P = 0.04, P = 0.007, P = 0.03, and P = 0.01, respectively). Although the highest intensity of light tolerated was measured with lens 6, 71% of blepharospasm patients reported the greatest relief of photophobia with lens 7.
CONCLUSIONS: Blepharospasm patients tolerate a lower intensity of light when compared with normal subjects; this differential in light tolerance becomes significantly more pronounced as the higher wavelengths of the visible spectrum are blocked. The symptoms of photophobia in blepharospasm patients can be reduced significantly with photochromatic modulation. Despite lens 6 allowing the patients to tolerate a higher intensity of light, the majority of patients preferred lens 7 for symptomatic relief of photophobia. These findings suggest that sensory photophobia may be related more to the wavelength than to the intensity of the light exposure.

Entities:  

Mesh:

Year:  2005        PMID: 16242188     DOI: 10.1016/j.ophtha.2005.06.030

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  12 in total

Review 1.  Update on blepharospasm: report from the BEBRF International Workshop.

Authors:  Mark Hallett; Craig Evinger; Joseph Jankovic; Mark Stacy
Journal:  Neurology       Date:  2008-10-14       Impact factor: 9.910

2.  Altered regional spontaneous neuronal activity in blepharospasm: a resting state fMRI study.

Authors:  Jing Yang; ChunYan Luo; Wei Song; Qin Chen; Ke Chen; XuePing Chen; XiaoQi Huang; QiYong Gong; HuiFang Shang
Journal:  J Neurol       Date:  2013-07-31       Impact factor: 4.849

Review 3.  Blepharospasm 40 years later.

Authors:  Giovanni Defazio; Mark Hallett; Hyder A Jinnah; Antonella Conte; Alfredo Berardelli
Journal:  Mov Disord       Date:  2017-02-10       Impact factor: 10.338

4.  A Potential Preclinical Migraine Model: CGRP-Sensitized Mice.

Authors:  Andrew F Russo; Adisa Kuburas; Eric A Kaiser; Ann C Raddant; Ana Recober
Journal:  Mol Cell Pharmacol       Date:  2009

5.  The effect of bangerter occlusion foils on blepharospasm and hemifacial spasm in occlusion-positive and occlusion-negative patients.

Authors:  Raman Malhotra; Siew-Yin Then; Alison Richards; Elizabeth Cheek
Journal:  Open Ophthalmol J       Date:  2010-01-15

Review 6.  The focal dystonias: current views and challenges for future research.

Authors:  H A Jinnah; Alfredo Berardelli; Cynthia Comella; Giovanni Defazio; Mahlon R Delong; Stewart Factor; Wendy R Galpern; Mark Hallett; Christy L Ludlow; Joel S Perlmutter; Ami R Rosen
Journal:  Mov Disord       Date:  2013-06-15       Impact factor: 10.338

7.  Blepharospasm in Japan: A Clinical Observational Study From a Large Referral Hospital in Tokyo.

Authors:  M Wakakura; A Yamagami; M Iwasa
Journal:  Neuroophthalmology       Date:  2018-01-09

8.  FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm.

Authors:  Marcus K Blackburn; Randy D Lamb; Kathleen B Digre; A Gordon Smith; Judith E A Warner; Robert W McClane; Sanjeev D Nandedkar; Wendy J Langeberg; Richard Holubkov; Bradley J Katz
Journal:  Ophthalmology       Date:  2009-05       Impact factor: 12.079

9.  Effect of light on blinking in patients with idiopathic isolated blepharospasm.

Authors:  Yiwen Wu; Hyun Joo Cho; Pattamon Panyakaew; Charulata Sankhla Savant; Tianxia Wu; Nguyet Dang; Mark Hallett
Journal:  Parkinsonism Relat Disord       Date:  2019-09-10       Impact factor: 4.891

10.  Effect of chromatic filters on visual performance in individuals with mild traumatic brain injury (mTBI): A pilot study.

Authors:  Vanessa Fimreite; Kevin T Willeford; Kenneth J Ciuffreda
Journal:  J Optom       Date:  2016-05-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.